Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,565 | 214 | 99.8% |
| Education | $5.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $605.30 | 42 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $522.98 | 21 | $0 (2019) |
| Abbott Laboratories | $321.62 | 10 | $0 (2020) |
| Novo Nordisk Inc | $310.45 | 42 | $0 (2019) |
| Lilly USA, LLC | $247.05 | 12 | $0 (2019) |
| Respiratory Technologies, Inc. | $186.47 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $169.17 | 16 | $0 (2018) |
| BOSTON SCIENTIFIC CORPORATION | $165.31 | 4 | $0 (2017) |
| PFIZER INC. | $157.54 | 13 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $131.75 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $82.66 | 5 | Abbott Laboratories ($34.63) |
| 2019 | $314.83 | 16 | SANOFI PASTEUR INC. ($90.53) |
| 2018 | $1,478 | 98 | Amgen Inc. ($405.67) |
| 2017 | $1,695 | 96 | Abbott Laboratories ($206.31) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2020 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/16/2020 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Bone Health | ||||||
| 03/23/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/18/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 01/14/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/19/2019 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/31/2019 | Medtronic Vascular, Inc. | VenaSeal (Device) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: EndoVenous Therapies | ||||||
| 09/14/2019 | Medtronic Vascular, Inc. | VenaSeal (Device) | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: EndoVenous Therapies | ||||||
| 09/06/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX, FLUARIX | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: VACCINES | ||||||
| 09/05/2019 | SANOFI PASTEUR INC. | DISEASE STATE (Drug) | Food and Beverage | In-kind items and services | $90.53 | General |
| 07/05/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: Oncology | ||||||
| 06/17/2019 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 05/14/2019 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 03/13/2019 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: VACCINES | ||||||
| 02/20/2019 | Teva Pharmaceuticals USA, Inc. | AJOVY (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Central Nervous System | ||||||
| 02/14/2019 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Bone Health | ||||||
| 02/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/23/2019 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Neuroscience | ||||||
| 01/16/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: DIABETES | ||||||
| 01/14/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Diabetes | ||||||
| 01/07/2019 | Amgen Inc. | Prolia (Biological), Repatha | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Bone Health | ||||||
| 12/20/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Obesity | ||||||
| 12/19/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2018 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BOOSTRIX | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: VACCINES | ||||||
| 12/15/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 6 | 197 | 412 | $76,605 | $22,157 |
| 2020 | 23 | 973 | 2,092 | $287,177 | $105,605 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 104 | $33,592 | $9,005 | 26.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 105 | $23,310 | $7,582 | 32.5% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2021 | 24 | 57 | $15,960 | $4,509 | 28.3% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2021 | 13 | 15 | $2,550 | $693.60 | 27.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 13 | 13 | $689.00 | $239.46 | 34.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 31 | 118 | $504.00 | $127.54 | 25.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 280 | 763 | $134,555 | $53,058 | 39.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 115 | 295 | $36,240 | $15,699 | 43.3% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2020 | 52 | 140 | $29,760 | $9,828 | 33.0% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2020 | 37 | 37 | $13,327 | $4,974 | 37.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 43 | 43 | $10,013 | $4,892 | 48.9% |
| J7321 | Hyaluronan or derivative, hyalgan or supartz, for intra-articular injection, per dose | Office | 2020 | 11 | 48 | $8,957 | $3,067 | 34.2% |
| 93925 | Ultrasound study of arteries and arterial grafts of both legs | Office | 2020 | 13 | 13 | $6,794 | $2,548 | 37.5% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Office | 2020 | 35 | 48 | $9,184 | $2,000 | 21.8% |
| 93978 | Ultrasound scan of vena cava or groin graft or vessel blood flow | Office | 2020 | 12 | 12 | $5,760 | $1,674 | 29.1% |
| 86328 | Ia nfct ab sarscov2 covid19 | Office | 2020 | 27 | 28 | $7,000 | $1,266 | 18.1% |
| 20550 | Injections of tendon sheath, ligament, or muscle membrane | Office | 2020 | 20 | 26 | $3,059 | $1,039 | 34.0% |
| 99497 | Advance care planning by the physician or other qualified health care professional | Office | 2020 | 21 | 21 | $3,380 | $989.14 | 29.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $4,727 | $953.90 | 20.2% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 47 | 47 | $1,760 | $829.28 | 47.1% |
| 93922 | Ultrasound study of arteries of both arms and legs | Office | 2020 | 15 | 15 | $3,600 | $513.71 | 14.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 45 | 49 | $4,476 | $487.95 | 10.9% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 25 | 25 | $1,125 | $479.25 | 42.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 70 | 372 | $1,183 | $419.48 | 35.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 25 | 25 | $750.00 | $414.50 | 55.3% |
About Dr. Dat Tran, M.D
Dr. Dat Tran, M.D is a Internal Medicine healthcare provider based in Goodyear, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720047566.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dat Tran, M.D has received a total of $3,570 in payments from pharmaceutical and medical device companies, with $82.66 received in 2020. These payments were reported across 215 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($3,565).
As a Medicare-enrolled provider, Tran has provided services to 1,170 Medicare beneficiaries, totaling 2,504 services with total Medicare billing of $127,762. Data is available for 2 years (2020–2021), covering 29 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Goodyear, AZ
- Active Since 03/21/2006
- Last Updated 11/17/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1720047566
Products in Payments
- Prolia (Biological) $305.60
- FARXIGA (Drug) $254.83
- Victoza (Drug) $228.42
- BYDUREON (Drug) $207.08
- Repatha (Biological) $205.14
- TRULICITY (Drug) $190.46
- CardioMEMS HF System (Device) $147.74
- CHANTIX (Drug) $121.04
- WATCHMAN DEVICE (Device) $116.49
- JANUVIA (Drug) $114.15
- DISEASE STATE (Drug) $90.53
- Aimovig (Biological) $79.09
- TOUJEO (Drug) $64.23
- LINZESS (Drug) $56.69
- BREO (Drug) $55.01
- JARDIANCE (Drug) $48.66
- SHINGRIX (Biological) $46.43
- Assurity Pacemaker (Device) $46.33
- Da Vinci Surgical System (Device) $43.27
- CRT-Ds (Device) $40.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Goodyear
Paramvir Sidhu, Md, MD
Internal Medicine — Payments: $34,086
Deepanshu Garg, M.d, M.D
Internal Medicine — Payments: $16,357
Dr. Sharad Chandrika, M.d, M.D
Internal Medicine — Payments: $14,448
Dr. Manav Jasrotia, Md, MD
Internal Medicine — Payments: $13,861
Jared Berkowitz, M.d, M.D
Internal Medicine — Payments: $2,953
Supriya Bhardwaj, Md, MD
Internal Medicine — Payments: $2,822